Positron Emission Tomography (PET) studies rely on a specialized tracer to visualize metabolic activity within the body. This tracer, FDG, is a modified sugar molecule that concentrates in areas of high metabolic demand. By introducing FDG into the bloodstream and tracking its distribution through PET scanners, clinicians can observe a wide range o